drug
as of 2026-07-01Individual Placement and Support (IPS)
Individual Placement and support (IPS)
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Charite University, Berlin, Germany
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
OTHER
Indications
Investigational (via trials)
SchizophreniaAcute and Transient Psychotic Disorder, UnspecifiedBipolar Affective DisorderBipolar DisorderMental DisordersSchizophreniaDepressive DisorderUnspecified Nonorganic PsychosisPsychotic DisordersRecurrent Depressive DisorderPersistent Delusional DisorderOther Nonorganic Psychotic DisordersSchizophrenia, Schizotypal and Delusional DisordersSchizoaffective DisorderSchizophrenia, Paranoid
Trials
2
KOLs & investigators
5
Andreas Bechdolf, Prof. Dr.KOL score 11
Merete Nordentoft, MD, PhD, MPHKOL score 8
Lene F Eplov, MD, PhdKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
KOL
Andreas Bechdolf, Prof. Dr.
personKOL score 11
Merete Nordentoft, MD, PhD, MPH
personKOL score 8
Lene F Eplov, MD, Phd
personKOL score 5
Bent Nielsen, Professor
personKOL score —